Loading
Latest filing published 14 Dec 2007 for Altus Pharmaceuticals Inc., €86k.
No signal scores available.
Sheldon Berkle appears in our data through filings on Altus Pharmaceuticals Inc. shares, published by SEC (Form 4). Over a trading history stretching from 1 November 2006 to 13 December 2007, the count stands at 25 filings.
Every open-market trade on record is a sale: 12 sales worth €1.0M. Besides market trades, the filings include 13 option exercises. So far in 2007, the count stands at no purchases and 9 sales.
The latest filing, published on 14 December 2007, reports an option exercise of €86k in Altus Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations